z-logo
Premium
Infectious complications after kidney transplantation: a single‐center experience
Author(s) -
Pourmand G.,
Salem S.,
Mehrsai A.,
Taherimahmoudi M.,
Ebrahimi R.,
Pourmand M.R.
Publication year - 2007
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/j.1399-3062.2007.00229.x
Subject(s) - medicine , incidence (geometry) , transplantation , pneumonia , kidney transplantation , prednisolone , pneumocystis pneumonia , mortality rate , cytomegalovirus , surgery , immunology , human immunodeficiency virus (hiv) , viral disease , physics , herpesviridae , optics , pneumocystis jirovecii
Infectious complications after renal transplantation are associated with significant morbidity and mortality. The prevalence of infections in transplant recipients varies from country to country. This study sought to assess the overall incidence of post‐transplant infectious complications at our research center in Iran, compared with other centers in the world. Between 2002 and 2004, 179 renal transplantations were performed in our center. Of these, 142 were studied and followed for 1 year. Immunosuppressive regimens were cyclosporine, mycophenolate mofetil, and prednisolone. The overall incidence of infections was 54.2%. The most common sites of infections were the urinary tract (41.5%) and the respiratory tract (6.3%). The most frequent causes of infections were Klebsiella (24%) and cytomegalovirus (CMV) (17.6%). Wound infection occurred in 4.9% of the patients. Three (2.1%) patients developed hepatitis C and 2 (1.4%) had mycobacterial infections. There was no case of Pneumocystis pneumonia. Overall mortality was 7.7%. Infection‐related mortality was 3.5%. In conclusion, this study identifies infections as the cause of morbidity and mortality in the post‐transplant period. There was a low incidence of tuberculosis (<2% yearly) and a high incidence of CMV disease in our recipients.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here